LIGAND PHARMACEUTICALS INC bought PTHS
July 1, 2025 · Form 4 insider transaction
LIGAND PHARMACEUTICALS INC bought 1,500,000 shares of Pelthos Therapeutics Inc. at $10.00 per share, a transaction worth $15.00M. The trade was recorded as conversion of a derivative and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
1,500,000
Price
$10.00
Total value
$15.00M
InsiderLIGAND PHARMACEUTICALS INC
RoleDirector, 10% owner
SecurityCommon Stock
Transaction codeC: Conversion of a derivative
Transaction dateJuly 1, 2025
Filing dateJuly 3, 2025
Shares owned after1,500,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The numbers reported herein have been adjusted to reflect the 1-for-10 reverse stock split effected by the Issuer on July 1, 2025.